Haffkine Ajintha Pharmaceuticals Limited, a active public limited state government company, was established on 22 April 1977 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1977SGC019615. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.77 M.
It upholds a compliant status. Its leadership includes Subhash Venkatrao Shankarwar (Nominee Director), Ravindra Dinkar Bapat (Director), Madhavi Suresh Chaware (Managing Director). Past directors included Prakash Ranganath Sabade, Anup Kumar Yadav, Rajesh Bhagwatrao Deshmukh. It holds no open charges and ₹7.01 Cr settled loans. Its latest AGM occurred on 29 December 2023, with the balance sheet filed on 31 March 2023. It is based at Haffkine Institute Compoundacharya Donde Marg Parel, Mumbai, Maharashtra, 400012.
U24239MH1977SGC019615
019615
22 April 1977
₹3.00 M
₹1.77 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Haffkine Ajintha Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhash Venkatrao Shankarwar | Nominee Director | 26 Mar 2015 | Current |
| Ravindra Dinkar Bapat | Director | 28 Dec 1999 | Current |
| Madhavi Suresh Chaware | Managing Director | 08 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 29 Jan 2013 | Past |
| Pramod Abcsdd | Managing Director | 17 Jun 2019 | Past |
| Pramod Abcsdd | Managing Director | 20 Aug 2020 | Past |
| Pramod Abcsdd | Managing Director | 08 Feb 2022 | Past |
| Pramod Abcsdd | Managing Director | 27 Nov 2020 | Past |
| Pramod Abcsdd | Managing Director | 05 Jan 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Haffkine Ajintha Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 213.98% increase. The company also saw a substantial improvement in profitability, with a 92.32% increase in profit. The company's net worth dipped by a decrease of 0.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Haffkine Ajintha Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹70,050,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jan 1998 | The United Western Bank Ltd | ₹1.50 Cr | Satisfied |
| 01 Oct 1991 | The United Western Bank Ltd | ₹3.00 M | Satisfied |
| 31 Jul 1990 | The United Western Bank Ltd | ₹2.30 M | Satisfied |
| 23 May 1985 | The United Western Bank Ltd | ₹4.35 Cr | Satisfied |
| 15 Dec 1979 | The United Western Bank Ltd | ₹0.30 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Haffkine Ajintha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Haffkine Ajintha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haffkine Ajintha Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Haffkine Ajintha Pharmaceuticals Limited last Annual general meeting of members was held on 29 Dec 2023 as per latest MCA records. was completed.
Progress on Haffkine Ajintha Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
The activity A charge registered on 01 Oct 1991 via Charge ID 90187544 with The United Western Bank Ltd was fully satisfied on 11 Oct 2022. was completed.
The activity A charge registered on 31 Jul 1990 via Charge ID 90187516 with The United Western Bank Ltd was fully satisfied on 11 Oct 2022. was completed.
A charge registered on 05 Jan 1998 via Charge ID 90188714 with The United Western Bank Ltd was fully satisfied on 28 Sep 2022. was recorded as a recent event.
Progress on A charge registered on 23 May 1985 via Charge ID 90184966 with The United Western Bank Ltd was fully satisfied on 22 Jun 2022. was documented.
The CIN of Haffkine Ajintha Pharmaceuticals Limited is U24239MH1977SGC019615.
Haffkine Ajintha Pharmaceuticals Limited is headquartered at Haffkine Institute Compoundacharya Donde Marg Parel, Mumbai, Maharashtra, 400012.
Haffkine Ajintha Pharmaceuticals Limited was incorporated on 22 April 1977.
The current directors of Haffkine Ajintha Pharmaceuticals Limited are
The primary industry of Haffkine Ajintha Pharmaceuticals Limited is Manufacturing.
Haffkine Ajintha Pharmaceuticals Limited is unlisted.
The authorized capital of Haffkine Ajintha Pharmaceuticals Limited is ₹3.00 M, and the paid-up capital is ₹1.77 M.
The compliance status of Haffkine Ajintha Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX